Business Context and Reporting Period
This Form 8-K was filed by MediciNova, Inc. on March 23, 2011. The report details a material definitive agreement for a public offering of common stock and warrants and provides preliminary unaudited financial results for the fourth quarter and fiscal year ended December 31, 2010.
Key Financial Metrics
- Revenue: The company does not expect to recognize any revenue for the quarter or year ended December 31, 2010.
- Net Loss (Q4 2010): Approximately $5.0 million ($0.40 per share).
- Net Loss (FY 2010): Approximately $20.2 million ($1.63 per share).
- Cash and Cash Equivalents: Approximately $28.3 million as of December 31, 2010.
- Restricted Cash: Approximately $28.7 million, expected to cover convertible debt obligations maturing June 18, 2011.
- Debt: Convertible debt obligations maturing on June 18, 2011.
- Offering Proceeds: Expected net proceeds of approximately $7.5 million from the sale of 2,750,000 units (stock and warrants).
Material Changes and Offering Details
On March 23, 2011, the company entered into an underwriting agreement with Ladenburg Thalmann & Co. Inc. to sell 2,750,000 units, each consisting of one share of common stock and one warrant to purchase one share. The offering price is $3.00 per unit, with the underwriter purchasing units at $2.85 per unit. Warrants are immediately exercisable at $3.56 per share and expire in five years. The offering is expected to close on or about March 29, 2011.
Outlook, Risks, and Management Commentary
Management states that the $28.3 million in cash and cash equivalents on hand will not be sufficient to meet operating requirements and debt repayment obligations through December 31, 2011. However, the restricted cash of $28.7 million is expected to be sufficient to cover the convertible debt maturing in June 2011. The financial results presented are preliminary and subject to the completion of the year-end audit. The filing includes standard forward-looking statement disclaimers regarding risks associated with the completion of the offering and future business operations.
Investor Verification Checklist
- Verify the final audited financial results for the year ended December 31, 2010, as current figures are preliminary.
- Confirm the closing of the $7.5 million offering and the actual net proceeds received.
- Monitor the company's cash burn rate to assess liquidity needs beyond the June 2011 debt maturity.
- Review the full text of the Underwriting Agreement (Exhibit 1.1) and Warrant form (Exhibit 4.1) for specific covenants and terms.
- Check for any updates on the status of the convertible debt repayment obligations.